nodeai.ca
Innovation Type:
Diagnostics
Cancer Type:
Lung
Funding Stage:
Pre-seed
Fund:
Falcons' Fortunes
Revolutionizing lung cancer care by leveraging cutting-edge AI to augment the precision and efficiency of lung biopsies in real-time for improved staging accuracy.

Related news

Hamilton, Ontario startup NodeAI wins Falcons’ Fortunes 2025 for revolutionary lung cancer diagnostics using artificial intelligence

The winning pitch at FACIT’s sold-out annual Falcons’ Fortunes pitch competition and recipient of the $100,000 Ernsting Entrepreneurship award was delivered by Dr. Waël Hanna, co-founder and Chief Medical Officer of NodeAI Diagnostics (“NodeAI”). The Hamilton, Ontario based start-up is leveraging the power of artificial intelligence to improve the speed and accuracy in evaluating and staging non-small cell lung cancer (NSCLC) patients. The innovation is poised to address a long standing gap in lung cancer diagnostics that can better inform treatment decisions and ultimately improved patient outcomes. Read More

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.